Compass Therapeutics, Inc.

Q4 2022 13F Holders

Symbol
CMPX
CUSIP
20454B104
Type
Equity
Class
COM
Num filings
57
Total reported value, excl. options
$403 M
Manager Report Date Value ($000) Shares Option Type